Klotho Neurosciences (KLTO) News Today $0.92 -0.04 (-4.55%) As of 08/1/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock KLTO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology | KLTO ...July 25, 2025 | gurufocus.comUPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond NeurologyJuly 25, 2025 | prnewswire.comKlotho Neurosciences, Inc. to Expand Development Programs Beyond NeurologyJuly 24, 2025 | prnewswire.comKlotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy AssetsJuly 22, 2025 | prnewswire.comKlotho Neurosciences regains full compliance with Nasdaq listing standardsJuly 16, 2025 | msn.comKlotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum Closing Bid Price and Stockholder Equity RulesJuly 16, 2025 | prnewswire.comKlotho Neurosciences stock soars after FDA grants orphan drug status ...July 11, 2025 | uk.investing.comKlotho Neurosciences stock soars after FDA grants orphan drug status for ALSJuly 10, 2025 | ca.investing.comKlotho Neurosciences Shares Jump as FDA Grants Orphan Drug Status for ALS TherapyJuly 10, 2025 | msn.comKlotho Neurosciences' ALS therapy awarded FDA Orphan Drug DesignationJuly 10, 2025 | proactiveinvestors.comKlotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")July 10, 2025 | prnewswire.comKLTO - Klotho Neurosciences Inc Chart - MorningstarJuly 2, 2025 | morningstar.comMKlotho Neurosciences Begins Manufacturing Gene Therapy for ALSJuly 2, 2025 | theglobeandmail.comKlotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALSJune 30, 2025 | prnewswire.comKlotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived PopulationJune 24, 2025 | prnewswire.comKLOTHO NEUROSCIENCES (KLTO) ANNOUNCES MUTUAL TERMINATION OF SHARE EXCHANGE AGREEMENT WITH SKYBELL TECHNOLOGIES (SKYBELL), TO CONTINUE ITS FOCUS ON THERAPEUTICS AND LONGEVITY PROGRAMSJune 18, 2025 | prnewswire.comKLOTHO NEUROSCIENCES RAISES OVER $11 MILLION, RETIRES ALL DEBT, AND EXCEEDS NASDAQ STOCKHOLDERS' EQUITY REQUIREMENTJune 16, 2025 | prnewswire.comBest Penny Stocks To Research - June 10thJune 10, 2025 | marketbeat.comKlotho Neurosciences: What's Behind The Nine-Fold Rise In KLTO Stock?June 10, 2025 | forbes.comKlotho Neurosciences Stock Skyrockets On Anti-Aging Gene Therapy Breakthrough: Retail Traders Over The MoonJune 10, 2025 | msn.comPenny Stocks To Watch Today - June 9thJune 9, 2025 | marketbeat.comPromising Small Cap Stocks Worth Watching - June 9thJune 9, 2025 | marketbeat.comKLOTHO NEUROSCIENCE, INC. ANNOUNCES AN APPROACH TO INCREASE LONGEVITY AND HEALTHY LIFE SPAN - REPLACE A SILENCED GENE CALLED ALPHA-KLOTHO ("α-KLOTHO")June 9, 2025 | prnewswire.comNasdaq Top 5 Premarket Losers: Healthcare Triangle, Klotho Neurosciences, New Fortress Energy, NanoVibronix, MDJMMay 15, 2025 | msn.comKlotho: A protein that promotes healthy aging and improves longevityMay 9, 2025 | msn.comKlotho Neurosciences faces Nasdaq delisting riskApril 23, 2025 | investing.comKlotho Neurosciences to Acquire SkyBell Tech SubsidiaryApril 3, 2025 | investing.comKlotho Neurosciences, Inc. (KLTO)February 2, 2025 | ca.finance.yahoo.comKlotho Neuroscience Inc (KLTO)January 28, 2025 | investing.comKlotho Neurosciences secures $2M in convertible notes and warrantsJanuary 24, 2025 | msn.comKlotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San FranciscoJanuary 8, 2025 | globenewswire.comDr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences' Scientific Advisory BoardDecember 9, 2024 | globenewswire.comFormer Merck USA President Joins Klotho Neurosciences' Board of DirectorsDecember 3, 2024 | globenewswire.comDr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific AdvisorOctober 23, 2024 | globenewswire.comCo-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho NeurosciencesOctober 15, 2024 | globenewswire.com Get Klotho Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLTO and its competitors with MarketBeat's FREE daily newsletter. Email Address KLTO Media Mentions By Week KLTO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KLTO News Sentiment▼0.000.46▲Average Medical News Sentiment KLTO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KLTO Articles This Week▼00▲KLTO Articles Average Week Get Klotho Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLTO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies enGene News Today Enanta Pharmaceuticals News Today SELLAS Life Sciences Group News Today Aclaris Therapeutics News Today Kyverna Therapeutics News Today Lifevantage News Today Citius Oncology News Today Alector News Today C4 Therapeutics News Today Nuvectis Pharma News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KLTO) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWall Street Laughed. Now They're Buying.For six months, I’ve been pounding the table on a major gold miner—while Twitter pundits laughed. But now, the...Golden Portfolio | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Create New Advertiser | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredTrump Did What!?Last May, President Trump signed four executive orders that could spark the biggest energy disruption in decad...Stansberry Research | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Klotho Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Klotho Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.